|
|
Post by mango on Sept 17, 2020 6:07:25 GMT -5
|
|
|
|
Post by goyocafe on Sept 17, 2020 6:46:01 GMT -5
Where’s the data? We’ve had this same information in different flavors for weeks.
|
|
|
|
Post by parrerob on Sept 17, 2020 7:47:44 GMT -5
Dr. Leone-Bay will present data on the Company's initial oral and inhaled cannabinoidderived product candidates at the 3rd International Cannabinoid Derived Pharmaceuticals Summit.
Summit will be from 15 to 17 September
Receptor should have been September 16 (Yesterday) but no way to find them at least from my side....
|
|
|
|
Post by neil36 on Sept 17, 2020 9:31:25 GMT -5
Well whatever she said yesterday, it definitely isn’t tanking the MNKD stock price!
|
|
|
|
Post by mango on Sept 17, 2020 18:00:02 GMT -5
I imagine it is pretty good data considering the level of prestige of the Summit. There’s some very high profile people and companies there, and generally people do not present clinical data at these sort of things if the data sucks.
ALB is scheduled to do another summit next year as well. Perhaps we will find out more about what RLS has in the coming months.
|
|
|
|
Post by mnkdfann on Sept 17, 2020 20:23:09 GMT -5
I'm sure it is fine, but I'm not sure how prestigious the summit is. This year's is only its 3rd offering.
|
|
|
|
Post by longliner on Sept 17, 2020 22:18:46 GMT -5
I'm sure it is fine, but I'm not sure how prestigious the summit is. This year's is only its 3rd offering. Dude....It's the most prestigious bunch of stoners on the planet.  |
|
|
|
Post by cretin11 on Sept 17, 2020 23:03:38 GMT -5
I'm sure it is fine, but I'm not sure how prestigious the summit is. This year's is only its 3rd offering. Dude....It's the most prestigious bunch of stoners on the planet. Nobody’s gonna remember anything they learn at this event. But they better have lots of snacks on hand. |
|
|
|
Post by mnkdfann on Sept 17, 2020 23:08:46 GMT -5
Dude....It's the most prestigious bunch of stoners on the planet. Nobody’s gonna remember anything they learn at this event. But they better have lots of snacks on hand. Doritos is a Platinum Sponsor. |
|
|
|
Post by pat on Sept 18, 2020 6:05:52 GMT -5
Nobody’s gonna remember anything they learn at this event. But they better have lots of snacks on hand. Doritos is a Platinum Sponsor. I just want one of those hemp T-shirts emblazoned with the MNKD logo....and a string bracelet... that the homeless guy with the dog is selling. |
|
|
|
Post by longliner on Sept 18, 2020 9:23:20 GMT -5
Doritos is a Platinum Sponsor. I just want one of those hemp T-shirts emblazoned with the MNKD logo....and a string bracelet... that the homeless guy with the dog is selling. Pat, I hate it when you say MNKD and homeless in the same post!  |
|
|
|
Post by LongMNKD on Sept 18, 2020 10:08:18 GMT -5
Will something with RLS have to go through the whole FDA approval process since it's using a known drug like cannabis? How could the process be quicker here? Sorry if this has been discussed just a thought i just had reading this thread haha
|
|
|
|
Post by mango on Sept 18, 2020 12:56:48 GMT -5
Will something with RLS have to go through the whole FDA approval process since it's using a known drug like cannabis? How could the process be quicker here? Sorry if this has been discussed just a thought i just had reading this thread haha GW Pharma’s is an oromucosal spray. There is other FDA approved cannabis-derived products as well. Some of the heavy lifting has been done. RLS will need a partner to carry it through trials unless they acquire the capital to do it themselves. I saw in a GW Pharma slide that they were considering inhaled versions of their products as well as oral. There are other big players in the game besides GW but that is just the most well known one. When I look at Kalytera Therapeutics, a great company BTW with really solid clinical data so far, they could really benefit from using Receptor’s oral technology and when I look at GW Pharma and their oromucosal spray and the limitations and drawbacks it brings—there’s a company right there that could greatly benefit from using Technosphere technology and MannKind‘s inhalers as this will not only overcome the inherent drawbacks and limitations of the spray, but also drastically improve efficacy, user satisfaction, precision, titration and costs as well. Let’s hope someone payed attention to ALB during this week’s presentation and is working on making a deal. |
|
|
|
Post by longliner on Oct 8, 2020 23:36:39 GMT -5
|
|
|
|
Post by sportsrancho on Oct 9, 2020 6:28:52 GMT -5
I wondered that same thing. But then I forgot about it until I saw this post. Ask Mike. |
|
